Liquid Biopsy space is getting crowded.

There are ~40 companies actively pursuing techniques for early cancer detection using simple blood draws, urine samples, et al.  And the space is getting crowded.  There is lots to do in this area to make it more efficient, cost-effective, and accurate.  New ventures will need to “find a lane” to race in to be successful.  Send me an email if you’d like to discuss this.